# Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers

> **NCT01656356** · PHASE1 · COMPLETED · sponsor: **Mahidol University**

## Conditions studied

- Preventive Avian Flu

## Interventions

- **BIOLOGICAL:** Avian Flu Vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01656356
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-08
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656356, "Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01656356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*